Gimeno JR, Olivotto I, Rodriguez AI, Ho CY, Fernandez A, Quiroga A, Espinosa MA, Gomez-Gonzalez C, Robledo M, Tojal-Sierra L, Day SM, Owens A, Barriales-Villa R, Larranaga JM, Rodriguez-Palomares J, Gonzalez-Del-Hoyo M, Piqueras-Flores J, Reza N, Chumakova O, Ashley EA, Parikh V, Wheeler M, Jacoby D, Pereira AC, Saberi S, Helms AS, Villacorta E, Gallego-Delgado M, de Castro D, Dominguez F, Ripoll-Vera T, Zorio-Grima E, Sanchez-Martinez JC, Garcia-Alvarez A, Arbelo E, Mogollon MV, Fuentes-Canamero ME, Grande E, Pena C, Monserrat L, Lakdawala NK; Dilema International Cardiomyopathy and Heart Failure Registry and international SHaRe (Sarcomeric Human Cardiomyopathy Registry) Investigators group. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry. ESC Heart Fail. 2022 Aug;9(4):2189-2198. doi: 10.1002/ehf2.13964. Epub 2022 Jun 3. PubMed PMID: 36255281; PubMed Central PMCID: PMC9288745.
AÑO: 2022; IF: 3.8